HPV-16 E6 protein inhibitor

DRUG CLASS:

News alerts, weekly reports and conference planners

Related drugs:

No biomarker	Head and Neck Cancer	No biomarker	Head and Neck Cancer	pembrolizumab + Versamune HPV Sensitive: B - Late Trials pembrolizumab + Versamune HPV Sensitive : B	pembrolizumab + Versamune HPV Sensitive: B - Late Trials pembrolizumab + Versamune HPV Sensitive : B
PD-L1 expression	Squamous Cell Carcinoma of Head and Neck	PD-L1 expression	Squamous Cell Carcinoma of Head and Neck	pembrolizumab + HB-200 Sensitive: C3 – Early Trials pembrolizumab + HB-200 Sensitive : C3	pembrolizumab + HB-200 Sensitive: C3 – Early Trials pembrolizumab + HB-200 Sensitive : C3

Associations(2)